Diabetic subjects are susceptible to atherosclerosis. It has been postulated that inflammation plays a crucial role in atherogenesis. Since previous studies suggested persistent low-grade infection by Gram-negative bacteria such as Chlamydia spp. and/or periodontal infection is associated with increased atherogenesis among diabetic subjects, we hypothesized that macrophages under hyperglycemia respond to lipopolysaccharide (LPS) challenge in a more exaggerated manner than under normal glucose conditions. Therefore, we examined cytokine productivity and associated signal transduction molecules in LPS-stimulated the monocytic cell line THP-1, under conditions of hyperglycemia. Differentiated THP-1 cells were cultured under normal and high glucose conditions without fetal bovine serum, and were stimulated with Escherichia coli LPS in the presence of LPS binding protein. Following stimulation, activated signal transduction molecules were detected by protein microarray and confirmed thereafter. Results indicated that c-jun N-terminal kinase (JNK) was highly-phosphorylated at high glucose concentrations, and this was confirmed by Westernimmunoblotting. Tumor necrosis factor-α and monocyte chemo-attractant protein-1 production were significantly enhanced under these conditions. SP600125, a selective inhibitor of JNK, dosedependently suppressed the production of these cytokine. Therefore, we suggest that this may be one of the mechanisms by which sub-clinical infection by Gram-negative bacteria promotes atherosclerosis in diabetic subjects.
INTRODUCTION
It is generally accepted that monocytes/macrophages play important roles in the pathogenesis of atherosclero-sis, and subsequent coronary heart diseases (CHD). CHD is a leading cause of mortality among diabetic subjects. Hyperglycemia plays a primary role in inducing atherogenesis among diabetic subjects. However, there is increasing evidence that strict blood glucose control alone is not enough to reduce the risk of developing CHD in diabetic subjects significantly. 1 Additionally, although the mortality rate in the diabetic population due to CHD far exceeds that observed in an age-matched, non-diabetic population, it is estimated that the contribution of all the commonly measured risk factors including hyperglycemia, hypertension, obesity, hyperinsulinemia, hypercholesterolemia, hypertriglyceridemia, and low levels of high density lipoprotein, all of which may often be more prevalent among diabetic subjects, together can account for no more than about 25% of the excess CHD in diabetics. 2 A previous study suggested that atherosclerosis is an inflammatory disease as well as metabolic disease. 3 Diabetic subjects often exhibit increased levels of circulating tumor necrosis factor-α (TNF-α), monocyte chemo-attractant protein-1 (MCP-1), interleukin-6 (IL-6) as well as markers for acute phase inflammation such as C-reactive protein. 4, 5 A major source of these cytokines in obese diabetic subjects appears to be adipose tissue; however, the precise cell types responsible for the production of these cytokines may not necessarily be adipocytes but might be macrophages infiltrated in the adipose tissues. 6 Additionally, non-obese diabetic subjects such as type 1 diabetics and others often exhibit increased levels of these inflammatory markers. 7, 8 It is generally accepted that monocytes/macrophages are primary cell types inducing these cytokines. Persistent, low-grade infectious diseases (such as chlamydial infection and/or periodontal disease 9,10 ) have been reported to play important roles in promoting atherosclerosis among diabetic subjects, suggesting that lipopolysaccharide (LPS)-induced inflammatory responses derived from Gram-negative bacteria accelerate atherosclerotic changes. Therefore, we hypothesized that macrophages may respond to LPS challenge in a more exaggerated manner under hyperglycemic conditions than under normal glucose conditions, and wished to see the effects of hyperglycemia on the activation of signal transduction molecules and subsequent cytokine production in LPSstimulated monocytic cells. However, culturing the cells with serum may greatly interfere with molecular analyses associated with signal transduction influenced by high-glucose conditions, as the effects of hyperglycemia were likely to be in the range of influencing chronic complications rather than causing acute adverse effects. To overcome this problem, we utilized a serum-free cell culture system and protein-microarray analyses to detect signal transduction molecules which were more highly activated by hyperglycemia than by normal glucose conditions. The purpose of the present study was to study the effects of hyperglycemia on the activation of signal transduction molecules associated with inflammatory cytokine production in LPS-stimulated monocytic cell lines.
MATERIALS AND METHODS

Cells and culture conditions
The human monocytic leukemia cell line THP-1 was differentiated and used for all experiments. Briefly, THP-1 cells were differentiated into a macrophage lineage as described previously. 11 The cells were maintained in RPMI-1640 medium containing 10% fetal bovine serum (FBS) and 100 nM phorbol 12-myristate 13-acetate (PMA). When the cells reached sub-confluence, the medium was changed to serum-and PMA-free RPMI-1640 containing either 5.5 mM or 25 mM glucose, and incubated for 24 h. In some experiments, medium containing 5.5 mM glucose and 19.5 mM mannitol was used as an osmotic control.
Protein microarray analyses
THP-1 cells (5 x 10 5 ) incubated either with 5.5 mM or 25 mM glucose without FBS were stimulated with 1 ng/ml of Escherichia coli LPS in the presence of 20 ng/ml of recombinant human LPS binding proteins (LBP: R & D Systems, Minneapolis, MN, USA). At 10 min after LPS stimulation, the cells were lysed with cell lysis buffer included in a Panorama Ab Microarray kit (Sigma, St Louis, MO, USA) according to the manufacture's instructions. The cell lysate was then labeled either with fluorescent dye Cy3 or Cy5 after measurement of the protein concentration. The same amount of protein samples were then applied to a Panorama Ab Microarray kit (Sigma) containing 224 different antibodies, and the reaction was performed according to the manufacture's instructions. Then, the fluorescent intensity was read using Array Worx (Amersham Biosciences, Bucks, UK) and the data were analyzed using the software Array Vision (Amersham Biosciences). To see the effects of hyperglycemia alone, a similar experiment was performed on the cells cultured for 24 h either with 5.5 mM or 25 mM glucose without FBS.
Western immunoblotting
Detection of tyrosine phosphorylated forms of c-jun Nterminal kinase (JNK), p38, ERK, and total JNK, p38, and ERK proteins was performed by Western immunoblotting. The cells were prepared as described above. At 10 min following LPS stimulation with LBP, 10 µg of protein samples obtained by cell lysis with cell lysis buffer (1% CHAPS, 2 mM Na 3 VO 4 , 1 mM NaF, 5 mM EDTA, proteinase inhibitor mixture [Roche Diagnostics GmbH, Mannheim, Germany] in 20 mM Tris-150 mM NaCl buffer, pH 7.6) were separated by SDS-PAGE, and blotted onto PVDF membrane. To detect JNK, p38, ERK and phospho-JNK, phospho-p38, phospho-ERK, rabbit anti human JNK, p38 and ERK polyclonal antibodies and rabbit anti human phospho-JNK, phosphor-p38, and phosphor-ERK polyclonal antibodies (all from Cell Signaling, Berverly, MA, USA) were used as primary antibody, respectively. Horseradish peroxidase conjugated anti-rabbit IgG (Amersham Biosciences) was used as a secondary antibody. Immunoreactive proteins were detected by the enhanced chemiluminescence method (ECL: Amersham Biosciences).
Cytokine array
To demonstrate the effects of hyperglycemia on cytokine production in LPS-stimulated THP-1 cells, 5 x 10 5 THP-1 cells were first incubated in a medium containing either 5.5 mM or 25 mM glucose, followed by the stimulation of the cells with 1 ng/ml of E. coli LPS and 20 ng/ml of LBP. Cell culture supernatant was obtained after 24 h of cell culture. The cytokine concentration in each culture supernatant was compared by using Cytokine Array (Ray Biotech, Inc., Norcross, GA, USA), which detects 63 kinds of different cytokines, according to the manufacture's instructions. Each chemiluminescent spot was then scanned and the relative intensity of each cytokine from the cells cultured under hyperglycemia against that from normal glucose was calculated by using NIH software Image J. The experiments were performed three times using distinct cell preparations.
Cytokine assay
TNF-α and MCP-1 concentrations in culture supernatants of LPS-stimulated cells (5 x 10 5 cells) cultured either with 5.5 mM or 25 mM glucose, or with 5.5 mM glucose plus 19.5 mM mannitol which served as osmotic control, were measured using a commercial immunoassay kit (human TNF-α, MCP-1 ELISA kit, Endogen Inc., Woburn, MA, USA) following 24 h of cell culture.
In some experiments, the cells were co-incubated with indicated concentrations of the JNK inhibitor, SP600125, or its negative control peptide (both from Calbiochem, La Jolla, CA, USA), or PKC inhibitor, GF109203X (Sigma), and the cytokine concentration in each culture supernatant was measured as described above. All experiments were performed in triplicate, and the data were subjected to statistical analysis.
Statistical analysis
Statistical analyses comparing TNF-α and MCP-1 productivity between the cells cultured with high glucose or with normal glucose, or between the cells cultured in the presence or absence of SP600125 were performed using Student's t-test.
RESULTS
To see the effects of hyperglycemia on signal transduction pathways in LPS-stimulated THP-1 cells, protein microarray analyses were performed first. We chose this array as this kit contained antibodies against all three kinds of MAP kinases as well as the activated form of PKC-β, which we thought served as a good positive control. Several phosphorylated forms of signal transducing molecules were highly expressed in the cells cultured hyperglycemically when stimulated with LPS (Table 1 ). Although it was not possible to detect total PKC with this kit, higher amounts of phosphorylated form of PKCβ were detected in the cells cultured under hyperglycemic conditions than in the cells cultured with normal glucose. In addition to PKC, focal adhesion kinase, proline-rich tyrosine kinase 2, and JNK were highly phosphorylated. However, other signaling molecules, including p38 and ERK MAP kinase family, were not affected by differential glucose conditions in THP-1 cells when stimulated by LPS. Interestingly, very few differences were observed between the cells cultured under high and normal glucose conditions without LPS stimulation, suggesting that the differential glucose concentration alone without LPS stimulation had minimum effect on the activity of signal transduction molecules in macrophages.
As enhanced JNK activity is usually associated with increased cytokine production in macrophages, we focused on JNK in subsequent experiments. Enhanced phosphorylation of JNK by high glucose was first confirmed by Western immunoblotting. The result is shown High glucose up-regulates LPS-stimulated inflammatory cytokine production 229 Table 1 . Signal transduction molecules expressed at higher levels in LPS-stimulated THP-1 cells exposed to hyperglycemia than in cells exposed to normal concentration of glucose in Figure 1A ,C. As indicated, phosphorylation of JNK-1, but not JNK-2, was enhanced in LPS-stimulated cells cultured hyperglycemically. Osmotic control did not affect the phosphorylation status of JNK-1. About 1.7 times higher phosphorylation of JNK was observed in LPS-stimulated cells cultured under hyperglycemia than in cells cultured under normal glucose conditions, and this was statistically significant ( Fig. 3C ; P < 0.05) based on three independent experiments. Furthermore, as demonstrated by protein array analysis as first screening, the phosphorylation of other MAP kinase families, p38 and ERK, was not influenced in this condition (Fig. 1B) .
Next, the effect of high glucose on inflammatory cytokine production was evaluated. We first compared the expression of several inflammatory cytokines by using cytokine array analysis. The results are summarised in Figure 2A and show MCP-1, RANTES, MIP-3, TNF-α, and IL-1β were highly expressed in LPS-stimulated cells cultured under hyperglycemic conditions as compared with cells cultured with normal glucose concentrations. This was confirmed by repeated experiments. When the reaction intensity of these cytokines was measured and compared, the expression of MCP-1, RANTES, MIP-3, TNF-α, and IL-1β were 2.04, 1.55, 1.46, 1.68, and 1.22 times higher in the cells with high glucose than in the cells with normal glucose, respectively. Statistical analysis based upon three independent protein array analyses revealed that expression 
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C levels of MCP-1 (P = 0.045), RANTES (P = 0.046), MIP-3 (P = 0.046), and TNF-α (P = 0.048) were statistically significant, while that of IL-1β was not (P = 0.178). In addition, we could not observe differential expression of other cytokines such as IL-4 and IL-6 in our experimental conditions, as the expression levels of these cytokines were very low. Because increased circulating MCP-1 and TNF-α levels are often discussed in terms of their relevance to the pathogenesis of atherosclerosis, we next investigated if production of these cytokine was up-regulated by a quantitative method. The data are shown in Figure 2B . Both TNF-α and MCP-1 production was up-regulated in LPS-stimulated THP-1 cells cultured under hyperglycemic conditions compared to cells cultured with normal glucose and glucose plus mannitol.
Finally, we investigated whether enhanced phosphorylation of JNK-1 under hyperglycemia was associated with higher production of TNF-α and MCP-1 in LPSstimulated macrophages. The effect of the JNK inhibitor, SP600125, on cytokine production was evaluated. The result is shown in Figure 3 . SP600125 inhibited both TNF-α and MCP-1 production in a dose-dependent manner (Fig. 3A) , while the control peptide for . At 24 h after LPS stimulation, TNF-α and MCP-1 production was measured by ELISA. SP600125 dosedependently inhibited TNF-α and MCP-1 (*P < 0.05) production in LPS-stimulated THP-1 cells precultured in high-glucose containing medium, while control peptide showed no inhibitory effects. In contrast, GF109203X also showed some inhibitory effect, although this did not exceed that of the JNK inhibitor (C). SP600125 showed no inhibitory effects (Fig. 3B ). As enhanced PKC activity has often been reported in relation to increased glucose conditions in other cell types such as endothelial cells, and PKC-β phosphorylation appeared to be enhanced in THP-1 cells under hyperglycemic conditions when stimulated by LPS, we next studied the effect of the PKC inhibitor, GF109203X, on these cytokine expression levels (Fig. 3C) . Although GF109203X showed some inhibitory effects on both TNF-α and MCP-1 expression in THP-1 cells, its inhibitory effect was far less than that observed with the JNK inhibitor, suggesting that high JNK activity was primarily responsible for the increased expression of these cytokines in LPS-stimulated THP-1 cells cultured under hyperglycemic conditions.
DISCUSSIONS
Pancreatic β-cell dysfunction and insulin resistance are common features of type 2 diabetes. Under diabetic and/or obese conditions, oxidative stress and endoplasmic reticulum stress have been reported to be induced in various tissues, leading to the activation of the JNK pathway. 12 Activated JNK, in turn, suppresses insulin biosynthesis as well as insulin signaling. 13 In fact, suppression of the JNK pathway in diabetic mice has been reported to improve insulin resistance and ameliorates glucose tolerance. 14 Therefore, much attention has been paid to hyperactivation of JNK with respect to the pathophysiology of diabetes. In this study, we found that hyperglycemia also activated JNK in an LPS-stimulated monocytic cell line, THP-1 as well as several other signaling molecules such as PKC-β and FAK. With respect to JNK, we demonstrated that hyperglycemia selectively activates the JNK pathway among three different MAP kinase cascades, which is of significance when considering inflammatory responses. Macrophages/monocytes are important cell types in the pathophysiology of atherosclerosis, which is more prevalent among diabetic subjects than non-diabetic subjects. Several studies have indicated the involvement of low-grade, persistent infections such as periodontal disease in the pathogenesis of atherosclerosis. 9,10 Therefore, it is possible that activated JNK not only influences diabetic pathology itself but also promotes vascular complications in diabetic subjects.
Hyperactivation of PKC has been reported in monocytes 15, 16 as well as in other cell types, such as endothelial cells, 17 exposed to hyperglycemia, and this has been attributed to the pathogenesis of diabetic vascular complications. In fact, higher amounts of the phosphorylated form of PKC-β were detected in LPS-stimulated THP-1 cells cultured under hyperglycemia than those under normal glucose conditions by protein microarray analysis. However, in this study, we hypothesized that, besides PKC, other signaling events might be pre-activated in macrophages exposed to hyperglycemia and these cells would respond to LPS challenge in an exaggerated manner. In fact, we confirmed that the effects of a JNK inhibitor (SP600125) on TNF-α production far exceeded than that of a PKC inhibitor in LPS-stimulated THP-1 cells cultured under hyperglycemic conditions (Fig. 3) . It is also possible that macrophage hyperactivation observed in this study partially accounts for the mechanisms by which diabetic subjects are prone to various infection-induced inflammatory diseases such as periodontal disease. In fact, monocytic TNF-α production in type 1 diabetic subjects has been reported to be higher than that in normal subjects. 18 Furthermore, upregulated TNF-α expression from hyperglycemiaprimed macrophages stimulated by bacterial LPS may further exacerbate insulin resistance, as recent findings indicated that macrophage infiltration in adipose tissues has been observed and these two cell types have been suggested to interact each others, thereby exacerbating the diabetes itself. 19, 20 
CONCLUSIONS
Certain Gram-negative infections such as periodontal disease have been reported to promote atherosclerosis. 9, 10 The hallmark feature of Gram-negative microorganisms is the common, highly immunogenic antigen LPS. Therefore, it is likely that monocytes pre-exposed to hyperglycemia respond to bacterial LPS in an exaggerated manner, and produce higher amounts of TNF-α and MCP-1 via the JNK pathway. Besides LPS, recent finding have suggested that fatty acids could activate Toll-like receptor 4, a receptor for LPS, on adipocytes and macrophages, thereby exacerbating insulin resistance. 21 Therefore, if this was the case, it is quite possible that both circulating LPS and fatty acids, hence infection and obesity, could activate macrophages in diabetic subjects and may further promote vascular changes via the JNK pathway.
